A medication plan for the vulnerable population is crucial in ensuring that the patients especially those with multiple comorbidities receive the best treatment to suit their needs. Some of the patient populations at risk are the senior citizens, patients with mental disorders, or those who have problems with medication compliance because of their impaired cognition or motor skills. This article will help the reader understand how to evaluate, recommend, and manage medications in such patients as well as offer important education and interventions regarding medication compliance.
Assessing the Most Appropriate Medication Based on Patient Characteristics
The first important step in the development of a medication plan for vulnerable patients is the evaluation of the patient’s profile. This entails their age, medical history, symptoms at presentation and any other factors that would affect the choice of drug. For instance, an old man, who is likely to have developed dementia, will require a different set of medications from a young man with a psychiatric illness.
When choosing the medication for an 82-year-old male with cognitive decline and mild neurocognitive disorder, the medication should be aimed to treat cognitive symptoms without having negative side effects. Memantine which is an NMDA receptor antagonist is usually the best medication to be prescribed to patients with mild to moderate Alzheimer’s disease or neurocognitive disorders. It achieves this by modulating the activity of glutamate which is involved in learning and memory. Memantine is usually administered at a dose of 5 mg/day and may be increased up to 20 mg/day depending on the patient’s tolerability and response to treatment.
On the other hand, drugs such as lorazepam which is a benzodiazepine should be avoided in elderly patients since they cause sedation, confusion and may lead to falls. Another medication that can be used to treat agitated patients is olanzapine, an atypical antipsychotic drug, which should be used in severe cases because it has side effects such as weight gain, metabolic disorders, and others.
Choosing the right medication requires the patient, the doctor and the pharmacist to consider the effectiveness of the drug, the side effects and the compatibility of the drug regimen with the patient’s lifestyle. When developing a medication plan for vulnerable populations, it is crucial to consider that the selected medication is safe and effective in managing the symptoms and has minimal side effects.
Dosing, Education, and Monitoring for Safe Medication Use
After the right medication has been selected, it is important to set the correct dosing regimen and ensure that the patient (and any caregivers if any) understands the proper way of administering the medication. This is important in developing a medication plan for vulnerable groups since the right dose and timings of the medication will enhance the desired effect and reduce the side effects.
For instance, a child with GAD (like a 10-year-old boy with constant worrying) may be prescribed fluoxetine which is an SSRI. The initial dose of the children is usually in the range of 5-10 mg per day, and the dose may be adjusted according to the patient’s reaction. Fluoxetine belongs to selective serotonin reuptake inhibitors and it acts by increasing serotonin levels in the brain which helps in enhancing mood and anxiety. However, just like with any other drug, there are side effects that should be observed for, though they are not very severe. Some of the side effects include nausea, headache, changes in appetite, and others, which are usually experienced when the medication is first administered.
Medication education includes the purpose of the medication, what the patient should expect to happen, and the risks involved and the need to take the medication as prescribed. The patient should be informed about the medication and the rationale for its use, as well as the correct way to use it safely. For instance, if a patient is given Memantine for cognitive decline, one must tell the patient that it does not treat Alzheimer’s but can help by enhancing the patient’s cognitive ability.
Also, there is a need to monitor the efficacy and the side effects frequently. For instance, a 33-year-old female diagnosed with postpartum depression and who is breastfeeding her baby, the use of sertraline which is an SSRI can be recommended. However, the patient should regularly be observed for side effects like changes in weight, stomach upset, or any change in mood. Blood tests may be required occasionally to assess any influence on the liver as some drugs, for instance, antidepressants, can affect liver enzymes.
For those living in vulnerable situations especially those with impaired cognitive abilities, the family members and caregivers are often involved in the management of medications. They can help monitor compliance, identify side effects, and make sure that the patient stays on the particular treatment plan. Also, follow-up visits or even phone calls to the healthcare providers can be useful to evaluate the effectiveness of the medications and the possible changes in the treatment plan.
Addressing Nonadherence and Developing a Comprehensive Care Plan
Nonadherence is one of the most critical issues in the administration of medications to the vulnerable groups. It can be due to forgetfulness, confusion, lack of understanding about the purpose of the medication, or due to side effects that make it unbearable to continue using the medication. The following are the barriers that need to be addressed when developing an effective medication plan for the vulnerable populations:
Schizophrenia for instance, may involve symptoms like paranoia or delusions that may hinder the patient from taking the medication as prescribed, hence the need to involve the family, mental health practitioners and caregivers. For a 27-year-old male with schizophrenia who has difficulty in remembering to take paliperidone palmitate which is a long-acting injectable antipsychotic medication, it can be prescribed. This form of medication helps the patient to have a constant flow of the medication without the need of taking it daily. The dosing regimen is self-administered and it has been found that the administration of the injections should be done every four weeks to enhance compliance and reduce the risk of relapse of the symptoms.
Nevertheless, the knowledge of the patient is critical in increasing medication compliance as stated below. The patient and his/her family should be informed of the implications of noncompliance to the prescription which may lead to deterioration of symptoms or relapse of the disease. Also, the treatment regimens should be made as simple as possible to minimize cases of missing doses. For instance, having blister packs or using reminders through phone applications are useful in ensuring that the patients take the medication on time.
Other measures include ensuring that there is adequate support in terms of health care providers, mental health care givers, and home based care givers. Such people can remind, prompt, and support emotionally. It is also possible to educate the family members on the signs of nonadherence like missing a dose or refusing to take the medication and seek help from the healthcare team.
For those patients who may still require some difficulty in following these strategies, there may be need to adopt other forms of treatment or medication. This might entail changing the patient to other drugs that do not have side effects, administering the drugs at other times of the day that are convenient for the patient, or even trying out non-pharmacological treatments like psychotherapy or cognitive behavioral therapy.
Conclusion
The process of developing a medication plan for vulnerable populations is complex and includes the identification of the patient’s needs, choice of the right medication and constant evaluation of its effectiveness and safety. Compliance, patient counseling, and techniques to enhance compliance are among the most important aspects of treatment. Thus, the healthcare providers should be aware of the issues that affect the vulnerable groups to enhance the patients’ quality of life. Whether it is in case of medication, family participation, or check-up, a multifaceted and sensitive approach is essential in managing the condition.
Effective Medication Plan for Vulnerable Populations Question
You will consider the specific patient and determine the appropriate medication to prescribe, based on the patient specifics and medication attributes in various case studies. You will construct a 4- to 5-page paper in which you determine the medication, the dosing, necessary patient education, and potential side effects. You will also indicate why the other medications would not be appropriate, as well as any necessary labs or diagnostics that might be needed. You will develop a plan to enhance medication adherence for the nonadherent patient.
Special Considerations for Patient Population Cases:
- Patient 1: 82-year-old male presenting with cognitive decline. He had always been a very active individual. Over the past year, he has become less active in the community. Previously, he played cribbage weekly with friends at the local senior center but has been struggling with the math involved with the game and no longer attends the weekly card game. He had also volunteered as a crossing guard for the local public school. He quit doing that after he took the wrong turn to get home and drove around the town feeling lost. He acknowledges he is “sensitive” to this and can be irritable towards his children when they bring up these concerns. He was diagnosed with mild neurocognitive disorder after completing neuropsychological testing. Of the following medications, which would be the most appropriate to prescribe? Explain why you chose this medication. What would be the dosing schedule for this patient? Provide education to the patient and review risks, benefits, and potential side effects of the medication. In addition, explain why the other medications listed are not appropriate for this patient. Med List: lorazepam, olanzapine, memantine
- Patient 2: 76-year-old female who recently moved from her home to an assisted living. After 1 week of moving in, she has become extremely confused. Staff have attempted to re-orient her, and she struggles to focus on what they are saying. She is only oriented to self. She has become very agitated and has even thrown breakable objects in her room. Her family is concerned stating she is “out of it.” The PCP ordered labs and UA. Labs are unremarkable outside of mild leukocytosis and positive dipstick analysis for nitrite and red blood cells. Med List: valproate, alprazolam, trimethoprim
- Patient 3: A 33-year-old female that is 6 weeks postpartum. She presents with depressed mood, sadness, easily emotional, difficulties with sleep even when the infant is sleeping. She has lost weight and has a poor appetite. You note psychomotor retardation. She has limited interests in hobbies or bonding with the infant. Her partner is concerned and reports she is typically active and “bubbly” and enjoys the outdoors. She is diagnosed with major depressive disorder, with postpartum onset. She denies suicidal ideation, homicidal ideation, or infanticidal ideation. No psychotic symptoms are present. She is nursing the infant and wants to continue this hoping it will assist with bonding with the infant. Med List: lithium, paroxetine, sertraline
- Patient 4: 10-year-old male who comes in with his father. He has been diagnosed with generalized anxiety disorder. He has constant worries that he cannot control. He feels nervous and tense. He is easily irritable. He struggles to settle down or relax. He is also quite fidgety and restless. He and his father are interested in medications to manage these symptoms. Med List: quetiapine, duloxetine, fluoxetine
- Patient 5: 27-year-old male with a diagnosis of schizophrenia. He has been hospitalized three (3) times in the past 1 year due to symptoms. When symptomatic, he becomes disorganized and paranoid. He will respond to auditory hallucinations. He will scream out at night after seeing a shadow in his room. He has delusions that the CIA is poisoning food and will not eat for multiple days. He has unintentionally hurt his mother after “slapping” food out of her hand, as he did not want her to ingest the “poisoned food.” Symptoms are treated very well with paliperidone, but he struggles to remember to take it. Med List: paliperidone palmitate, clozapine, lamotrigine
Construct a paper concerning your assigned vulnerable population patient case. In your paper include the following:
- Determine which medication would be most appropriate to prescribe from the assigned vulnerable population patient case medication choices.
- Explain your rationale for choosing this medication. Explain why the other medications listed are not appropriate for this patient.
- Explain the dosing schedule for the specific patient including the therapeutic endpoint.
- Provide necessary education to the patient to review risks, benefits, and potential side effects of the medication.
- Describe any necessary labs or additional diagnostics needed prior to prescribing this medication.
- Explain how you might monitor efficacy or side effects of the medication.
- Include any additional collaboration or education to others that would be necessary for this patient. Consider family members, home health care, primary care providers, etc.
- What would you need to include in your assessment for a patient who may become nonadherent with your prescribing plan for your scenario? What are alternative treatment solutions based upon how you assessed? Describe your new treatment plan.
PART 2
Create prescriptions using the patient information, medications, and indications listed below. Your goal is to demonstrate the accurate way to write a prescription that a patient would present to a pharmacy. The prescription should be written and signed. You will develop your mock prescriptions in a word document to include everything one might find on a printed prescription pad. You will write one prescription per page.
To write your prescriptions, please use the following patient information:
Patient Name: Jane Doe
DOB 1/1/2001
Duration: 3 months
Write a prescription for each of the following medications:
Sertraline, 100mg each day (depression)
Lorazepam, 1mg twice each day, if needed (panic attacks)
Aripiprazole, 2mg before bedtime (depression)
Methylphenidate ER, 54mg every morning before school (ADHD)
Order an Essay Now & Get These Features For Free:
Turnitin Report
Formatting
Title Page
Citation
Outline
